{"schema_version":"1","generated_at":"2026-11-05T09:02:46.508Z","data_as_of":"2026-11-04","url":"https://www.findmykol.com/kol/alicia-lenzen","json_url":"https://www.findmykol.com/kol/alicia-lenzen/profile.json","record_kind":"full","profile_kind":"clinical","person":{"slug":"alicia-lenzen","name":"Alicia Lenzen","credential":"MD","title":"Attending Physician, Hematology, Oncology, Neuro-Oncology & Stem Cell Transplantation","specialty":"Hematology / Oncology","specialty_raw":"Pediatric Hematology-Oncology","therapeutic_area":"Neuro-Oncology","therapeutic_areas":["Neuro-Oncology","Leukemia"],"institution":"Ann & Robert H. Lurie Children's Hospital of Chicago","institution_url":"https://www.findmykol.com/institution/ann-robert-h-lurie-children-s-hospital-of-chicago","city":"Chicago","state":"IL","region":{"label":"Midwest","url":"https://www.findmykol.com/region/midwest"},"country":{"name":"United States","code":"US","status":"verified"}},"identifiers":{"npi":"1538424056","orcid":"0000-0002-9123-419X","openalex":"A5041376388"},"summary":"Alicia Lenzen is Attending Physician, Hematology, Oncology, Neuro-Oncology & Stem Cell Transplantation at Ann & Robert H. Lurie Children's Hospital of Chicago. OpenAlex indexes 65 publications with 878 citations (h-index 9); ClinicalTrials.gov lists 3 registered studies with this person as an investigator.","overview":{"text":"Alicia Lenzen, M.D., is Attending Physician, Hematology, Oncology, Neuro-Oncology & Stem Cell Transplantation at Ann & Robert H. Lurie Children's Hospital of Chicago. The public record shows 65 publications with 878 citations (h-index 9), centered on Glioma Diagnosis and Treatment, Cancer Immunotherapy and Biomarkers, Immunotherapy and Immune Responses. It also documents an investigator role on 3 registered clinical trials.","bullets":["Most recent indexed publication: 2026 · Clinical cancer research","Top research focus: Glioma Diagnosis and Treatment","3 registered trials on ClinicalTrials.gov"],"generated_at":"2026-11-04"},"focus":{"indications":[{"label":"Neuro-Oncology / Glioma","therapeutic_area":"Oncology","trials":3,"topics":0,"strength":10},{"label":"Glioma","therapeutic_area":"Oncology","trials":3,"topics":0,"strength":9},{"label":"Central Nervous System Neoplasms","therapeutic_area":"Oncology","trials":1,"topics":0,"strength":3},{"label":"Diffuse Intrinsic Pontine Glioma","therapeutic_area":"Oncology","trials":1,"topics":0,"strength":3},{"label":"Ovarian / Gynecologic Cancer","therapeutic_area":"Oncology","trials":0,"topics":0,"strength":1},{"label":"Epilepsy","therapeutic_area":"Neurology","trials":0,"topics":0,"strength":1},{"label":"Sarcoma","therapeutic_area":"Oncology","trials":0,"topics":0,"strength":1},{"label":"Leukemia (AML/ALL/CML/CLL)","therapeutic_area":"Oncology","trials":0,"topics":0,"strength":1},{"label":"Melanoma","therapeutic_area":"Oncology","trials":0,"topics":0,"strength":1}],"research_topics":["Glioma Diagnosis and Treatment","Cancer Immunotherapy and Biomarkers","Immunotherapy and Immune Responses","Acute Lymphoblastic Leukemia research","Childhood Cancer Survivors' Quality of Life"],"works_with":{"total":3,"shown":3,"withheld":0,"rows":[{"name":"Alicia Lenzen","trials":1,"payments":0,"mentions":1},{"name":"BrainChild Bio, Inc","trials":1,"payments":0,"mentions":1},{"name":"University of California, San Francisco","trials":1,"payments":0,"mentions":1}]}},"scholarship":{"works_count":65,"cited_by_count":878,"h_index":9,"i10_index":7,"pubmed_count":2,"latest_activity_year":2026,"source":"works"},"trials":{"count":3,"shown":3,"withheld":0,"matched_by":"identity-adjudicated record","rows":[{"nct":"NCT07680439","title":"Illuminate: A Clinical Study Evaluating CAR T Immune Cell Therapy (BCB-276) for Patients With Diffuse Intrinsic Pontine Glioma (DIPG).","phase":"PHASE2","status":"RECRUITING","role":"Investigator","sponsor":"BrainChild Bio, Inc","source_url":"https://clinicaltrials.gov/study/NCT07680439","trial_url":"https://www.findmykol.com/trial/NCT07680439"},{"nct":"NCT07110246","title":"Dabrafenib and Trametinib for BRAF V600 Mutant Low-Grade Gliomas","phase":"PHASE2","status":"RECRUITING","role":"Investigator","sponsor":"University of California, San Francisco","source_url":"https://clinicaltrials.gov/study/NCT07110246","trial_url":"https://www.findmykol.com/trial/NCT07110246"},{"nct":"NCT02455245","title":"A Study Comparing Two Carboplatin Containing Regimens for Children and Young Adults With Previously Untreated Low Grade Glioma","phase":"PHASE3","status":"COMPLETED","role":"Investigator","sponsor":"Alicia Lenzen","source_url":"https://clinicaltrials.gov/study/NCT02455245","trial_url":"https://www.findmykol.com/trial/NCT02455245"}],"source":"trials"},"payments":{"company_count":0,"program_years":{"first":2021,"last":null},"rows_total":0,"shown":0,"withheld":0,"rows":[],"record_url":"https://openpaymentsdata.cms.gov/search?query=1538424056","source":"payments"},"funding":{"award_count":0,"rows_total":0,"shown":0,"withheld":0,"rows":[],"source":"grants"},"congress":{"count":10,"years":{"first":2018,"last":2026},"societies":["AACR","SNO"],"shown":3,"withheld":7,"rows":[{"title":"Abstract 1150: Combining CDK4/6 inhibitor with TMZ and radiation alters cell states for synergistic responses in orthotopic DIPG models","society":"AACR","meeting":"AACR Annual Meeting","year":2026,"role":"co_author","presentation_type":"unknown","contribution_type":"abstract","doi":"https://doi.org/10.1158/1538-7445.am2026-1150","source_url":"https://doi.org/10.1158/1538-7445.am2026-1150","status":"verified"},{"title":"Abstract 1167: The pan-CLK DYRK inhibitor SM09419 prolongs animal survival times in a subset of pediatric medulloblastoma patient-derived orthotopic xenograft mouse models.","society":"AACR","meeting":"AACR Annual Meeting","year":2026,"role":"co_author","presentation_type":"unknown","contribution_type":"abstract","doi":"https://doi.org/10.1158/1538-7445.am2026-1167","source_url":"https://doi.org/10.1158/1538-7445.am2026-1167","status":"verified"},{"title":"Abstract 1528: AZD5851, a TGF-β-resistant GPC3 CAR-T cell product, prolongs animal survival times in patient derived orthotopic xenograft models of medulloblastoma and atypical teratoid rhabdoid tumor","society":"AACR","meeting":"AACR Annual Meeting","year":2026,"role":"co_author","presentation_type":"unknown","contribution_type":"abstract","doi":"https://doi.org/10.1158/1538-7445.am2026-1528","source_url":"https://doi.org/10.1158/1538-7445.am2026-1528","status":"verified"}],"source":"congress"},"publications":{"total":2,"shown":2,"withheld":0,"matched_by":"ORCID record, linked to PubMed","recent":[{"title":"Pediatric Brain Tumor Consortium Phase I Study of CD40 Agonist Sotigalimab in Pediatric and Young Adult Patients with Recurrent CNS Tumors and Newly Diagnosed DIPG.","year":2026,"journal":"Clinical cancer research : an official journal of the American Association for Cancer Research","types":["Journal Article","Clinical Trial, Phase I","Multicenter Study"],"source_url":"https://pubmed.ncbi.nlm.nih.gov/42377093/","status":"verified"},{"title":"Using IT to Improve Outcomes for Children Living With Cancer (SyMon-SAYS): Protocol for a Single-Institution Waitlist Randomized Controlled Trial.","year":2023,"journal":"JMIR research protocols","types":["Journal Article"],"source_url":"https://pubmed.ncbi.nlm.nih.gov/37682593/","status":"verified"}],"most_cited":{"total":65,"shown":5,"withheld":60,"rows":[{"title":"IDO1 in cancer: a Gemini of immune checkpoints","year":2018,"cited_by_count":437,"type":"article","source_url":"https://doi.org/10.1038/cmi.2017.143"},{"title":"IDO1 Inhibition Synergizes with Radiation and PD-1 Blockade to Durably Increase Survival Against Advanced Glioblastoma","year":2018,"cited_by_count":203,"type":"article","source_url":"https://doi.org/10.1158/1078-0432.ccr-17-3573"},{"title":"Phase I trial of panobinostat in children with diffuse intrinsic pontine glioma: A report from the Pediatric Brain Tumor Consortium (PBTC-047)","year":2023,"cited_by_count":70,"type":"article","source_url":"https://doi.org/10.1093/neuonc/noad141"},{"title":"Lessons learned from rindopepimut treatment in patients with EGFRvIII-expressing glioblastoma","year":2018,"cited_by_count":35,"type":"article","source_url":"https://doi.org/10.21037/tcr.2018.03.36"},{"title":"A phase 2 PBTC study of selumetinib for recurrent/progressive pediatric low-grade glioma: Strata 2, 5, and 6 with long-term outcomes on strata 1, 3, and 4","year":2025,"cited_by_count":21,"type":"article","source_url":"https://doi.org/10.1093/neuonc/noaf065"}]},"source":"publications"},"network":{"coauthors_total":37,"shown":3,"withheld":34,"coauthors":[{"name":"Jason Fangusaro","coauthored_works":20,"profile_url":"https://www.findmykol.com/kol/jason-fangusaro"},{"name":"Ira J. Dunkel","coauthored_works":17},{"name":"Lijie Zhai","coauthored_works":16}],"source":"works"},"presence":{"owned_accounts":{"total":1,"shown":1,"rows":[{"platform":"doximity","url":"https://www.doximity.com/pub/alicia-lenzen-md","status":"provisional"}]},"mentions":{"total":2,"shown":2,"rows":[{"url":"https://www.cancer.northwestern.edu/research/membership/profile.html?id=a87515bb719b2167e887dd08e245faa3","platform":"other","status":"provisional"},{"url":"https://www.feinberg.northwestern.edu/faculty-profiles/az/profile.html?xid=42605","platform":"other","status":"provisional"}]},"verified_means":"confirmed in more than one place; provisional means found and still being confirmed"},"recognition":{"education":{"total":1,"shown":1,"rows":[{"value":"M.D. (Doctor of Medicine), The Warren Alpert Medical School of Brown University","source_url":"https://www.mothermcauley.org/alumnae/events/mcauley-hall-of-honor/2024-inductees/alicia-thompson-lenzen-02","status":"verified","collected_at":"2026-11-04"}]},"roles":{"total":1,"shown":1,"rows":[{"value":"Program Director, Pediatric Neuro-Oncology Fellowship","source_url":"https://research.luriechildrens.org/en/researchers/alicia-c-lenzen/","status":"verified","collected_at":"2026-11-04"}]},"awards":{"total":2,"shown":2,"rows":[{"value":"Inducted into Mother McAuley Hall of Honor (2024)","source_url":"https://www.mothermcauley.org/alumnae/events/mcauley-hall-of-honor/2024-inductees/alicia-thompson-lenzen-02","status":"provisional","collected_at":"2026-11-04"},{"value":"Rory David Deutsch Malignant Brain Tumor Research Scholar","source_url":"https://research.luriechildrens.org/en/researchers/alicia-c-lenzen/","status":"verified","collected_at":"2026-11-04"}]},"secondary_affiliations":{"total":1,"shown":1,"rows":[{"value":"Assistant Professor of Pediatrics (Hematology, Oncology, and Stem Cell Transplantation), Northwestern University Feinberg School of Medicine","source_url":"https://www.pediatrics.northwestern.edu/faculty/hemonc.html?ch=L","status":"verified","collected_at":"2026-11-04"}]}},"similar":[{"name":"Patrick Wen","slug":"patrick-wen","institution":"Dana-Farber Cancer Institute","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/patrick-wen","json_url":"https://www.findmykol.com/kol/patrick-wen/profile.json"},{"name":"Minesh Mehta","slug":"minesh-mehta","institution":"Florida International University Herbert Wertheim College of Medicine","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/minesh-mehta","json_url":"https://www.findmykol.com/kol/minesh-mehta/profile.json"},{"name":"David Reardon","slug":"david-reardon","institution":"Dana-Farber Cancer Institute","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/david-reardon","json_url":"https://www.findmykol.com/kol/david-reardon/profile.json"},{"name":"Timothy Cloughesy","slug":"timothy-cloughesy","institution":"Ronald Reagan UCLA Medical Center","specialty":"Neurology","url":"https://www.findmykol.com/kol/timothy-cloughesy","json_url":"https://www.findmykol.com/kol/timothy-cloughesy/profile.json"}],"coverage":{"note":"An identity-adjudicated profile: every section above was checked. Where a section states a count of zero, the public record was searched and nothing was found."},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"congress":7,"network":34}},"sources":{"orcid":{"name":"ORCID","url":"https://orcid.org","provides":"The verified researcher identity that anchors authorship"},"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts","collected_at":"2026-11-04"},"trials":{"name":"ClinicalTrials.gov","url":"https://clinicaltrials.gov","provides":"Investigator roles on registered clinical studies","collected_at":"2026-11-04"},"payments":{"name":"CMS Open Payments","url":"https://openpaymentsdata.cms.gov","provides":"Industry payments reported to CMS, by company and program year","disclaimer":"Payments are publicly reported to CMS. Their existence does not imply wrongdoing; CMS does not interpret these data.","coverage":"Program years 2021 onward"},"grants":{"name":"NIH RePORTER","url":"https://reporter.nih.gov","provides":"Federally funded research awards, by fiscal year"},"congress":{"name":"OpenAlex","url":"https://openalex.org","provides":"DOI-verified congress abstracts across AACR, ASCO, ASH, ASTRO, ESMO","disclaimer":"Congress abstracts are published as DOI-bearing journal supplements and attributed via the same ORCID-disambiguated authorship as publications.","collected_at":"2026-11-04"},"publications":{"name":"PubMed (NLM)","url":"https://pubmed.ncbi.nlm.nih.gov","provides":"Peer-reviewed publications, linked to the PubMed record","collected_at":"2026-11-04"}},"methodology_url":"https://www.findmykol.com/about#methodology"}